Publications by authors named "B C Narmada"

Background & Aims: Hepatitis B surface antigen (HBsAg) loss or functional cure (FC) is considered the optimal therapeutic outcome for patients with chronic hepatitis B (CHB). However, the immune-pathological biomarkers and underlying mechanisms of FC remain unclear. In this study we comprehensively interrogate disease-associated cell states identified within intrahepatic tissue and matched PBMCs (peripheral blood mononuclear cells) from patients with CHB or after FC, at the resolution of single cells, to provide novel insights into putative mechanisms underlying FC.

View Article and Find Full Text PDF

Background And Aims: Single nucleotide polymorphism rs6903956 has been identified as one of the genetic risk factors for coronary artery disease (CAD). However, rs6903956 lies in a non-coding locus on chromosome 6p24.1.

View Article and Find Full Text PDF

Background: Bistable behaviors are prevalent in cell signaling and can be modeled by ordinary differential equations (ODEs) with kinetic parameters. A bistable switch has recently been found to regulate the activation of transforming growth factor-β1 (TGF-β1) in the context of liver fibrosis, and an ordinary differential equation (ODE) model was published showing that the net activation of TGF-β1 depends on the balance between two antagonistic sub-pathways.

Results: Through modeling the effects of perturbations that affect both sub-pathways, we revealed that bistability is coupled with the signs of feedback loops in the model.

View Article and Find Full Text PDF
Article Synopsis
  • Atherosclerosis leads to various cardiovascular diseases, and nutraceuticals are gaining attention for their potential to improve vascular health, but their complex ingredients complicate efficacy evaluation.
  • Researchers created a coculture system using human pluripotent stem cell-derived endothelial cells and hepatocytes to study the vascular-protective effects of nutraceuticals like quercetin and genistein.
  • While quercetin and genistein alone didn’t reduce inflammation, the combination with hepatocytes helped generate bioactive metabolites that reduced inflammatory responses, demonstrating the coculture model's ability to predict nutraceutical efficacy and metabolic interactions.
View Article and Find Full Text PDF

Pluripotent stem cell derived hepatocyte-like cells (hPSC-HLCs) are an attractive alternative to primary human hepatocytes (PHHs) used in applications ranging from therapeutics to drug safety testing studies. It would be critical to improve and maintain mature hepatocyte functions of the hPSC-HLCs, especially for long-term studies. If 3D culture systems were to be used for such purposes, it would be important that the system can support formation and maintenance of optimal-sized spheroids for long periods of time, and can also be directly deployed in liver drug testing assays.

View Article and Find Full Text PDF